Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Analyst Ratings

Analyst Ratings

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings

7 Analysts Have This to Say About Axalta Coating Sys

By Benzinga Insights
July 11, 10:19 AM
Over the past 3 months, 7 analysts have published their opinion on Axalta Coating Sys (NYSE:AXTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

AXTA

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

B of A Securities Downgrades Allegion to Underperform, Lowers Price Target to $110

By Benzinga Newsdesk
July 11, 10:18 AM
B of A Securities analyst Andrew Obin downgrades Allegion (NYSE:ALLE) from Neutral to Underperform and lowers the price target from $130 to $110.

ALLE

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Truist Securities Maintains Hold on Physicians Realty Trust, Lowers Price Target to $17

By Benzinga Newsdesk
July 11, 10:00 AM
Truist Securities analyst Michael Lewis maintains Physicians Realty Trust (NYSE:DOC) with a Hold and lowers the price target from $18 to $17.

DOC

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Cowen & Co. Downgrades CytomX Therapeutics to Market Perform

By Benzinga Newsdesk
July 11, 9:58 AM
Cowen & Co. analyst Boris Peaker downgrades CytomX Therapeutics (NASDAQ:CTMX) from Outperform to Market Perform.

CTMX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Tronox Holdings, Lowers Price Target to $23

By Benzinga Newsdesk
July 11, 9:54 AM
Barclays analyst Michael Leithead maintains Tronox Holdings (NYSE:TROX) with a Overweight and lowers the price target from $25 to $23.

TROX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Equal-Weight on Olin, Lowers Price Target to $52

By Benzinga Newsdesk
July 11, 9:52 AM
Barclays analyst Michael Leithead maintains Olin (NYSE:OLN) with a Equal-Weight and lowers the price target from $65 to $52.

OLN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Jefferies Maintains Buy on Hancock Whitney, Lowers Price Target to $55

By Benzinga Newsdesk
July 11, 9:50 AM
Jefferies analyst Casey Haire maintains Hancock Whitney (NASDAQ:HWC) with a Buy and lowers the price target from $60 to $55.

HWC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Truist Securities Maintains Buy on Equitable Holdings, Lowers Price Target to $38

By Benzinga Newsdesk
July 11, 9:44 AM
Truist Securities analyst Mark Hughes maintains Equitable Holdings (NYSE:EQH) with a Buy and lowers the price target from $42 to $38.

EQH

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on LyondellBasell Industries, Lowers Price Target to $110

By Benzinga Newsdesk
July 11, 9:42 AM
Barclays analyst Michael Leithead maintains LyondellBasell Industries (NYSE:LYB) with a Overweight and lowers the price target from $130 to $110.

LYB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Equal-Weight on Dow, Lowers Price Target to $60

By Benzinga Newsdesk
July 11, 9:38 AM
Barclays analyst Michael Leithead maintains Dow (NYSE:DOW) with a Equal-Weight and lowers the price target from $72 to $60.

DOW

Posts pagination

Previous 1 … 4,349 4,350 4,351 … 4,420 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service